Logo
x

Search category

Subscribe Now

All Posts by Date

Zomedica Acquires Assisi’s Assets and Provide Drug-Free Solution for Treating Pain

Zomedica Acquires Assisi’s Assets and Provide Drug-Free Solution for Treating Pain

  • July 18, 2022
Barbara Klencke, CMO at Sierra Oncology (now GSK) Shares Insights on the Significant benefits obtained from the Pivotal Myelofibrosis Study

Barbara Klencke, CMO at Sierra Oncology (now GSK) Shares Insights on the Significant benefits obtained from the Pivotal Myelofibro...

  • July 18, 2022
PureTech Founded Entity Akili Reports Investigator-Initiated Study Results of AKL-T01 for Systemic Lupus Erythematosus

PureTech Founded Entity Akili Reports Investigator-Initiated Study Results of AKL-T01 for Systemic Lupus Erythematosus

  • July 18, 2022
AbbVie Reports Submission of MAA to EMA for Atogepant to Treat Migraine

AbbVie Reports Submission of MAA to EMA for Atogepant to Treat Migraine

  • July 18, 2022
Azurity’s Zonisade Receives the US FDA’s Approval for Partial Seizures in Adults and Pediatric Patients with Epilepsy

Azurity’s Zonisade Receives the US FDA’s Approval for Partial Seizures in Adults and Pediatric Patients with Epilepsy

  • July 18, 2022
SIGA Collaborated with KaliVir Immunotherapeutics to Supply Tpoxx for the Treatment of Smallpox

SIGA Collaborated with KaliVir Immunotherapeutics to Supply Tpoxx for the Treatment of Smallpox

  • July 18, 2022
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.